SCHEMBL1727655

SCHEMBL1727655

Cc1ccc2nc(NC(=O)c3ccc(S(=O)(=O)C4CCc5ccccc5N4)cc3)sc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.59
MEN1 O00255 7/20 0.59
KMT2A Q03164 7/20 0.59
KDM4E B2RXH2 6/20 0.59
MAPT P10636 5/20 0.59
RAB9A P51151 9/20 0.53
NPC1 O15118 8/20 0.53
RXFP1 Q9HBX9 3/20 0.52
MAP3K5 Q99683 1/20 0.52
ALDH1A1 P00352 6/20 0.51
LMNA P02545 2/20 0.51
BLM P54132 1/20 0.51
PAX8 Q06710 1/20 0.51
HPGD P15428 4/20 0.49
MAPK1 P28482 2/20 0.49
GAA P10253 1/20 0.49
LRRK2 Q5S007 1/20 0.49
HTT P42858 2/20 0.48
KLK7 P49862 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1727944 0.90 LRRK2 (0.59) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL1728185 0.90 MAPT (0.55) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL1726609 0.84 MAPT (0.54) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL1727649 0.83 MEN1 (0.60) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL1728196 0.81 LMNA (0.50) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL1728020 0.80 KMT2A (0.60) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL1726674 0.77 NPC1 (0.52) SMN1; SMN2MEN1KMT2AMAPTRAB9A
SCHEMBL5713530 0.76 MAP3K5 (0.75) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL1726841 0.76 PHGDH (0.60) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL1726833 0.75 KDM4A (0.60) SMN1; SMN2MEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406236-A1 RHO KINASE INHIBITORS Surface Logix, Inc. (US) 2012-01-18 EP disclosed
EP-2403499-A2 METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL Stemsynergy Therapeutics, Inc (US) 2012-01-11 EP disclosed
WO-2010104851-A1 RHO KINASE INHIBITORS SURFACE LOGIX, INC. (US) 2010-09-16 WO disclosed
WO-2010101964-A2 METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL STEMSYNERGY THERAPEUTICS, INC (US) 2010-09-10 WO disclosed